Original filing (PDF)20250729133401NAL0003953216001

ENTERIS BIOPHARMA, INC.

Name: ENTERIS BIOPHARMA, INC. — ENTERIS BIOPHARMA, INC. 401(K) PLAN, Form 5500 (2024)
Creator: ENTERIS BIOPHARMA, INC.

Form 5500-SF

FILING_RECEIVED

ENTERIS BIOPHARMA, INC. 401(K) PLAN

401(k) retirement plan

Active participants

Accounts w/ balance

Plan assets (EOY)

$10.0M

Net assets (EOY)

$10.0M

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for ENTERIS BIOPHARMA, INC..

Plan sponsor

Name

ENTERIS BIOPHARMA, INC.

EIN

46-2487187

Address

83 FULTON STREET · BOONTON, NJ · 07005

Phone

(973) 453-3531

Industry

Professional & Technical Servicessee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-07-29

Pension benefit codes

2E · Profit-sharing

2G · Total participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

3D · Pre-approved plan (master / prototype / VS)

2T · Default investment account (QDIA)

Audit & trust (Schedule H)

Auditor

—

Trustee / custodian

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Professional & Technical Services plans

TENAYA THERAPEUTICS, INC.

TENAYA THERAPEUTICS, INC. 401(K) PLAN

$10.0M · 98 participants

FULCRUM THERAPEUTICS, INC.

FULCRUM THERAPEUTICS, INC. 401(K) PLAN

$10.0M · 49 participants

LAS CUMBRES OBSERVATORY GLOBAL TELESCOPE NETWORK, INC.

LAS CUMBRES OBSERVATORY 403(B) DC PLAN

$9.9M · 31 participants

HEADLANDS RESEARCH, INC.

HEADLANDS RESEARCH 401(K) PLAN

$10.1M · 365 participants

SB TECHNOLOGY, INC.

FORUS 401(K)

$9.8M · 176 participants